MARKET NEWS

English
Specials
Moneycontrol Be a PRO
you are here:
Success
Alert
Please select a Day.
Info
Open Trading Account

Ajanta Pharma Ltd.

Sector: Pharmaceuticals
Add to
1,991.15
-7.50 (-0.38%)

As on 16 Jun, 2021 | 03:53

Trade
Day Range
1984.95
2025.00
L H
52 Week Range
1331.00
2049.00
L H
Volume
91,853
*
i

* BSE Market Depth (16 Jun 2021)

BUY SELL
QTY PRICE PRICE QTY
1 1981.00 1995.00 24
1 1975.00 2000.00 43
2 1970.00 2004.00 30
4 1967.95 2008.00 174
2 1962.20 2008.45 15
1024 Total Total 2370
Bid / Ask
1970.00 / 1990.05
Advance Chart
1,990.05
-2.95 (-0.15%)

As on 16 Jun, 2021 | 03:40

Day Range
1984.40
2024.00
L H
52 Week Range
1330.00
2047.85
L H
Volume
6,368
*
i

* BSE Market Depth (16 Jun 2021)

BUY SELL
QTY PRICE PRICE QTY
1 1981.00 1995.00 24
1 1975.00 2000.00 43
2 1970.00 2004.00 30
4 1967.95 2008.00 174
2 1962.20 2008.45 15
1024 Total Total 2370
Bid / Ask
1970.00 / 1990.05
Advance Chart
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
MC Essentials
81% Pass
MC Technicals
 Trend
i
This represents current trend.Click here for disclaimer.
MC Insights

Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

Financials
    Ownerships
      Industry Comparison
        Others
          Powered by Powered by Trendlyne
          Open2,007.00
          Previous Close1,998.65
          UC Limit2,398.35
          LC Limit1,598.95
          Volume91,853.00
          VWAP2,003.98
          Mkt Cap (Rs. Cr.)17,230
          20D Avg Volume86,785
          20D Avg Delivery--
          Beta0.280.25
          Face Value2.00
          TTM EPS75.56
          TTM PE26.35
          Sector PE38.44
          Book Value Per Share346.18
          P/B5.75
          Dividend Yield0.48
          P/C22.38

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          MC Insights

          Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 49.71% away from 52 week low
          • 2.82% away from 52 week high
          • Underperformer - Ajanta Pharma up by 1.52% v/s NIFTY 50 up by 7.42% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          6

          indicates Average Financials

          3 year CAGR growth
          Revenue 10.7%
          NetProfit 11.7%
          OperatingProfit 14.9%
          Industry Comparison
          • TTM PE Ratio - Above industry Median
          • Market Cap - High in industry
          • Price to Book Ratio - Above industry Median
          • TTM PEG Ratio - Above industry Median
          Shareholding Pattern
          • Promoters pledged 0.32% of shares in last quarter. Total pledge stands at 15.49% of promoter holdings
          • Promoters holding remains unchanged at 70.34% in Mar 2021 qtr
          • Mutual Funds have decreased holdings from 9.78% to 9.53% in Mar 2021 qtr
          • Number of MF schemes decreased from 16 to 15 in Mar 2021 qtr
          • FII/FPI have increased holdings from 7.9% to 8.37% in Mar 2021 qtr.
          • Number of FII/FPI investors decreased from 184 to 176 in Mar 2021 qtr
          • Institutional Investors have increased holdings from 20.37% to 20.99% in Mar 2021 qtr.
          Powered by Powered by Trendlyne

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Historical Prices
          Volume Analysis

          News

          Ajanta Pharma renews residential lease in posh Mumbai apartment for Rs 18 lakh a month

          Ajanta Pharma renews residential lease in posh Mumbai apartment for Rs 18 lakh a month

          Jun 09 2021 05:06 PM

          ₹ Earning + See More

          Forum

          Community Sentiments

          Data not Available

          What's your call on today?

          Read 4 investor views

          BUY SELL HOLD
          POST

          Broker Research

          01 May, 2021

          ICICIdirect.com

          Reco Price 1841.70 Target Price 2250
          03 Feb, 2021

          Dolat Capital

          Reco Price 1799.05 Target Price 2208
          02 Feb, 2021

          Motilal Oswal

          Reco Price 1746.15 Target Price 2030
          Thomson Reuters Report

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          18 Apr, 2019

          KOTAK MAHINDRA (INTERNATIONAL) LTD

          Qty 505977 Price 1033 % Traded 0.58
          17 Jan, 2013

          RBA FINANCE AND INVEST CO

          Qty 350000 Price 399.44 % Traded 0.40
          17 Jan, 2013

          RBA FINANCE AND INVEST CO

          Qty 150000 Price 397.5 % Traded 0.17
          17 Jan, 2013

          RAMJIDAS & SONS

          Qty 350000 Price 399.44 % Traded 0.40
          17 Jan, 2013

          RAMJIDAS & SONS

          Qty 150000 Price 397.5 % Traded 0.17
          16 May, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 66758 Price 278.92 % Traded 0.08
          16 May, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 66758 Price 279.75 % Traded 0.08
          11 Apr, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 114454 Price 232.14 % Traded 0.13

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          + Show More
          Powered by Powered by Trendlyne

          Insider Transaction Summary

          16 Jun, 2021

          Ravi Agrawal, trustee Ravi Agrawal Trust

          Promoter
          Qty 150000 Price 1998.65 % Traded 0.17 Post Tnx Hold. 14.37%
          16 Jun, 2021

          Satish Agrawal

          Designated Person
          Qty 3717 Price 2003.39 % Traded 0.00 Post Tnx Hold. 0.07%
          09 Jun, 2021

          MATTHEW PAUL EDELSON

          Designated Person
          Qty 900 Price 1889.97 % Traded 0.00 Post Tnx Hold. 0%
          09 Jun, 2021

          MATTHEW PAUL EDELSON

          Designated Person
          Qty 100 Price 1902.62 % Traded 0.00 Post Tnx Hold. 0%
          09 Jun, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 61000 Price 1951.65 % Traded 0.07 Post Tnx Hold. 14.36%
          09 Jun, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 142000 Price 1951.65 % Traded 0.16 Post Tnx Hold. 14.36%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Show All Transactions
          11 Jul, 2017

          Ganga Exports,a Partnership Firm

          Promoter
          Qty 2700000 Price 0 % Traded 3.07 Post Tnx Hold. 0.37%
          21 Nov, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Other
          Qty 2703360 Price 0 % Traded 3.08 Post Tnx Hold. 0%
          21 Nov, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 1.53 Post Tnx Hold. 3.07%
          21 Nov, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 3.07 Post Tnx Hold. 3.07%
          10 Nov, 2016

          Yogesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 3.08 Post Tnx Hold. 0%
          26 Sep, 2016

          Yogesh M Agrawal

          Other
          Qty 30839779 Price 0 % Traded 35.06 Post Tnx Hold. 0%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend
          Insights
          Institutional Holder Analysis Total Number Change Total Holding (%) Change
          MF Schemes (Mar 2021) 15 -1 9.53 -0.25
          FII/FPI (Mar 2021) 126 -7 8.37 0.47

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Ajanta Pharma 1,991.15 -0.38 17,229.77 26.35 5.75 21.82 34.85 653 2,889 0.00
          Sun Pharma 668.55 -0.69 160,407.54 54.09 3.24 6.24 38.30 2,284 33,498 0.07
          Divis Labs 4,300.70 -0.29 114,170.07 57.53 12.28 21.34 85.35 1,984 6,969 0.00
          Dr Reddys Labs 5,406.10 -0.09 89,927.40 46.08 5.10 11.06 34.97 1,903 19,047 0.17
          Cipla 956.75 -1.34 77,161.26 32.08 4.83 13.12 50.01 2,401 19,159 0.08
          + See More

          About the Company

          Ajanta Pharma Limited (APL), is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales. They cater to therapeutic areas like cardiology, ophthalmology and dermatology.They manufacture various dosage forms such as tablets, capsules, injections, ointments and powders. The companys research and development division conduct activities in three aspects namely new drug delivery system (NDDS), formulation and development and herbal/ nutraceutical.
          {"success":1,"data":{"address":{"address1":"\"Ajanta House\",","address2":"Charkop,,Kandivli (West),","city":"Mumbai","state":"Maharashtra","pincode":"400067","telephone1":"022-66061000","telephone2":"","fax1":"022-66061200","fax2":"022-66061300","email":"info@ajantapharma.com","web":"http:\/\/www.ajantapharma.com"},"management":[{"name":"Mannalal B Agrawal","designation":"Chairman"},{"name":"Madhusudan B Agrawal","designation":"Vice Chairman"},{"name":"Yogesh M Agrawal","designation":"Managing Director"},{"name":"Rajesh M Agrawal","designation":"Joint Managing Director"},{"name":"Chandrakant M Khetan","designation":"Independent Director"}],"registrars":{"name":"Link Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"532331","nseId":"AJANTPHARM","series":"EQ","isinid":"INE031B01049"}}}

          • Registered Office

          • Registrars

          • Management

            • Mannalal B Agrawal

              Chairman

            • Madhusudan B Agrawal

              Vice Chairman

            • Yogesh M Agrawal

              Managing Director

            • Rajesh M Agrawal

              Joint Managing Director

            • Chandrakant M Khetan

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              532331

            • NSE:

              AJANTPHARM

            • Series

              EQ

            • ISIN

              INE031B01049

          Go to Top

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>

          Sections
          Desktop Version »
          Follow us on
          Facebook Twitter Instagram Teglegram Jio News
          Available On
          Download from Google Play Download from App Stoer Download from Windows Phone
          Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us | Advertise with Us
          Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

          Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.